Sumitomo Mitsui Trust Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.92M | Buy |
113,315
+15,294
| +16% | +$1.07M | ﹤0.01% | 688 |
|
|
2025
Q1 | $7.2M | Buy |
98,021
+12,894
| +15% | +$948K | 0.01% | 710 |
|
|
2024
Q4 | $5.58M | Buy |
85,127
+616
| +0.7% | +$40.4K | ﹤0.01% | 736 |
|
|
2024
Q3 | $6.58M | Buy |
84,511
+9,795
| +13% | +$763K | ﹤0.01% | 741 |
|
|
2024
Q2 | $5.83M | Sell |
74,716
-4,157
| -5% | -$324K | ﹤0.01% | 743 |
|
|
2024
Q1 | $5.34M | Buy |
78,873
+13,373
| +20% | +$906K | ﹤0.01% | 815 |
|
|
2023
Q4 | $4.41M | Sell |
65,500
-84
| -0.1% | -$5.66K | ﹤0.01% | 825 |
|
|
2023
Q3 | $4.44M | Buy |
65,584
+12,249
| +23% | +$830K | ﹤0.01% | 837 |
|
|
2023
Q2 | $3.82M | Sell |
53,335
-10,108
| -16% | -$723K | ﹤0.01% | 856 |
|
|
2023
Q1 | $4.4M | Buy |
63,443
+370
| +0.6% | +$25.7K | ﹤0.01% | 844 |
|
|
2022
Q4 | $4.28M | Buy |
63,073
+5,391
| +9% | +$366K | ﹤0.01% | 854 |
|
|
2022
Q3 | $3.16M | Sell |
57,682
-1,901
| -3% | -$104K | ﹤0.01% | 900 |
|
|
2022
Q2 | $3.94M | Buy |
59,583
+674
| +1% | +$44.5K | ﹤0.01% | 884 |
|
|
2022
Q1 | $3.91M | Buy |
58,909
+25,369
| +76% | +$1.68M | ﹤0.01% | 882 |
|
|
2021
Q4 | $1.95M | Sell |
33,540
-3,420
| -9% | -$199K | ﹤0.01% | 946 |
|
|
2021
Q3 | $2.22M | Sell |
36,960
-280
| -0.8% | -$16.8K | ﹤0.01% | 938 |
|
|
2021
Q2 | $2.23M | Buy |
37,240
+8,549
| +30% | +$512K | ﹤0.01% | 943 |
|
|
2021
Q1 | $1.43M | Buy |
+28,691
| New | +$1.43M | ﹤0.01% | 971 |
|